Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Early Response Evaluation”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)WithdrawnNCT05774886
What this trial is testing

Implantable Microdevice for TNBC - Pilot Study

Who this might be right for
Triple Negative Breast CancerBreast Cancer Stage IIBreast Cancer Stage III+4 more
Dana-Farber Cancer Institute
Not applicableUnknownNCT00969098
What this trial is testing

Response Evaluation in Malignant Pleural Mesothelioma

Who this might be right for
Malignant Pleural Mesothelioma
Istituto Clinico Humanitas 150
Testing effectiveness (Phase 2)Looking for participantsNCT07698535
What this trial is testing

Measuring Circulating Tumor Deoxyribonucleic Acid Tumor Fraction to Guide Early 177Lu-PSMA-617 Treatment Discontinuation in Patients With Metastatic Castration-Resistant Prostate Cancer, DYNAMO Trial

Who this might be right for
Metastatic Castration-Resistant Prostate AdenocarcinomaStage IVB Prostate Cancer AJCC v8
University of Washington 64
Not applicableLooking for participantsNCT06673225
What this trial is testing

INSPIRE Respiratory Health Program in Botucatu, São Paulo, Brazil

Who this might be right for
Community Health ServicesRespiratory DiseaseTobacco Smoking
UPECLIN HC FM Botucatu Unesp 2,000
Large-scale testing (Phase 3)Study completedNCT01779206
What this trial is testing

ADAPT - Adjuvant Dynamic Marker-Adjusted Personalized Therapy Trial Optimizing Risk Assessment and Therapy Response Prediction in Early Breast Cancer

Who this might be right for
Breast Cancer
Women's Cancer Study Group GmbH 4,936
Not applicableEnded earlyNCT00645359
What this trial is testing

Pilot Study of dMRI as a Tool for Early Evaluation of Tumor Response in Diffuse Large B-cell Lymphoma

Who this might be right for
Diffuse Large B Cell Lymphoma
University of Michigan Rogel Cancer Center 9
Early research (Phase 1)Ended earlyNCT02891616
What this trial is testing

18F-FLT PET Imaging in Patients With Advanced Melanoma

Who this might be right for
Melanoma
Washington University School of Medicine 4
Not applicableNot Yet RecruitingNCT06193122
What this trial is testing

Three-Dimensional Ultrasound and Spectroscopy as Early Indicators of Breast Cancer Response to Neoadjuvant Treatment

Who this might be right for
Breast Cancer
Sunnybrook Health Sciences Centre 200
Not applicableStudy completedNCT00748241
What this trial is testing

Study to Evaluate Implant Survival Rate of Astra Tech Fixture ST in the Posterior Maxilla With One-stage Surgery and Early Loading

Who this might be right for
Jaw, Edentulous, Partially
Dentsply Sirona Implants and Consumables 19
Testing effectiveness (Phase 2)Ended earlyNCT00696943
What this trial is testing

18F ML-10 for Early Detection of Response of Brain Metastases to SRS

Who this might be right for
Metastasis to Brain of Unknown Primary
Aposense Ltd. 1
Not applicableLooking for participantsNCT06755619
What this trial is testing

CtDNA for Early Response Assessment in PCNSL Treated with 1st Line Curative Intent (NLG-PCNSL-01)

Who this might be right for
Primary Central Nervous System (CNS) Lymphoma
Nordic Lymphoma Group 60
Large-scale testing (Phase 3)Study completedNCT01521923
What this trial is testing

A Multi-center, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Certolizumab Pegol in Combination With Methotrexate in the Treatment of Disease Modifying Antirheumatic Drugs (DMARD)-naïve Adults With Early Active Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis
UCB Pharma 359
Not applicableUnknownNCT06455956
What this trial is testing

Use of miRNAs in Growth Hormone Deficiency (GHD)

Who this might be right for
Growth Hormone Deficiency
University of Parma 400
Not applicableStudy completedNCT01956019
What this trial is testing

MRI in Pre-operative Radiotherapy for Soft Tissue Sarcoma: MISTS Study

Who this might be right for
Sarcoma
The Christie NHS Foundation Trust 15
Not applicableWithdrawnNCT01314677
What this trial is testing

Fludeoxyglucose F 18 PET/CT Scans in Predicting Therapy Response in Patients With Stage IIIA Non-Small Cell Lung Cancer Undergoing Chemoradiation

Who this might be right for
Stage IIIA Non-small Cell Lung Cancer
City of Hope Medical Center
Testing effectiveness (Phase 2)Study completedNCT00748306
What this trial is testing

Study in Mild Asthmatic Patients

Who this might be right for
Asthma
GlaxoSmithKline 19
Testing effectiveness (Phase 2)Study completedNCT00392314
What this trial is testing

Tailored Therapy for Hodgkin Lymphoma Using Early Interim Therapy PET for Therapy Decision.

Who this might be right for
Hodgkin Lymphoma
Rambam Health Care Campus 365
Not applicableLooking for participantsNCT07516678
What this trial is testing

Serial ctDNA and Molecular Residual Disease Monitoring in Neuroblastoma

Who this might be right for
Neuroblastoma
Sun Yat-sen University 200
Post-approval studies (Phase 4)Ended earlyNCT02204722
What this trial is testing

Evaluate Efficacy and Safety of Glinib in Newly Diagnosed CML Patients

Who this might be right for
Chronic Myeloid Leukemia
Dong-A ST Co., Ltd. 55
Testing effectiveness (Phase 2)Study completedNCT01756352
What this trial is testing

FET-PET for Evaluation of Response of Recurrent GBM to Avastin

Who this might be right for
Glioblastoma MultiformeGBM
Marcelo F. Di Carli, MD, FACC 13
Next Page